Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Mar 21;13:111–121. doi: 10.2147/VHRM.S106841

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2017 Chaudhry and Stewart. This work is published and licensed by Dove Medical Press Limited

The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed

PMC Copyright notice

Kaplan–Meier curves for key study outcomes in the PARADIGM-HF trial.

Notes: (A) Primary end point. (B) Death from cardiovascular causes. (C) Hospitalization for heart failure. (D) Death from any causes. From New England Journal of Medicine. McMurray JJ, Packer M, Desai AS, et al. Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure. 371(11):993–1004. Copyright © 2014 Massachusetts Medical Society. Reprinted with permission from Massachusetts Medical Society.¹⁸

Abbreviations: CI, confidence interval; PARADIGM-HF, Prospective Comparison of ARNI with an Angiotensin-Converting Enzyme Inhibitor to Determine Impact on Global Mortality and Morbidity in Heart Failure.